BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23904052)

  • 1. Isoxanthohumol modulates angiogenesis and inflammation via vascular endothelial growth factor receptor, tumor necrosis factor alpha and nuclear factor kappa B pathways.
    Negrão R; Duarte D; Costa R; Soares R
    Biofactors; 2013; 39(6):608-22. PubMed ID: 23904052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
    Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
    Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells.
    Lee TH; Jung H; Park KH; Bang MH; Baek NI; Kim J
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1325-34. PubMed ID: 24939823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
    Corsini M; Moroni E; Ravelli C; Andrés G; Grillo E; Ali IH; Brazil DP; Presta M; Mitola S
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling.
    De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A
    Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways.
    Kang JS; Yoon YD; Han MH; Han SB; Lee K; Lee KH; Park SK; Kim HM
    Mol Pharmacol; 2006 Mar; 69(3):941-9. PubMed ID: 16354764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
    Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
    Kim GD; Oh J; Jeong LS; Lee SK
    Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
    Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betaine inhibits in vitro and in vivo angiogenesis through suppression of the NF-κB and Akt signaling pathways.
    Yi EY; Kim YJ
    Int J Oncol; 2012 Nov; 41(5):1879-85. PubMed ID: 22940742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of catechin on angiogenesis and inflammation depending on VEGF levels.
    Negrão R; Costa R; Duarte D; Gomes TT; Azevedo I; Soares R
    J Nutr Biochem; 2013 Feb; 24(2):435-44. PubMed ID: 22704779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
    McGonigle JS; Giachelli CM; Scatena M
    Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
    Morais C; Gobe G; Johnson DW; Healy H
    Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
    Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
    Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.